Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.3K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.3K
Infection01:20

Infection

12.7K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
12.7K
Stages of Infection01:26

Stages of Infection

65.3K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
65.3K
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

9.8K
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
9.8K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.1K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.1K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.7K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NEMESIS: Noninferiority, Individual-Patient Metaanalysis of Selective Internal Radiation Therapy with <sup>90</sup>Y Resin Microspheres Versus Sorafenib in Advanced Hepatocellular Carcinoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2020
Same author

COVID-19: Don't Neglect the Gastrointestinal Tract!

Digestive diseases (Basel, Switzerland)·2020
Same author

Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative.

Helicobacter·2020
Same author

Gastric cancer in autoimmune gastritis: A case-control study from the German centers of the staR project on gastric cancer research.

United European gastroenterology journal·2020
Same author

Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center study.

BMC cancer·2020
Same author

"My Friend with HIV Remains a Friend": HIV/AIDS Stigma Reduction through Education in Secondary Schools-A Pilot Project in Buea, Cameroon.

Journal of the International Association of Providers of AIDS Care·2020

Related Experiment Video

Updated: Feb 7, 2026

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

1.2K

Helicobacter Pylori Infection.

Wolfgang Fischbach1, Peter Malfertheiner

  • 1Department II, Gastroenterology and Oncology, Klinikum Aschaffenburg - Alzenau GmbH, Academic Teaching Hospital of the University of Würzburg; Clinic for Gastroenterology, Hepatology, and Infectious Diseases, University Clinic Magdeburg.

Deutsches Arzteblatt International
|July 13, 2018
PubMed
Summary

Helicobacter pylori (H. pylori) infection management is dynamic due to changing resistance and new guidelines. Evidence-based strategies now enable effective H. pylori eradication, crucial for preventing gastroduodenal ulcers and gastric cancer.

More Related Videos

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
06:40

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

4.4K
Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology
05:13

Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology

Published on: June 13, 2025

775

Related Experiment Videos

Last Updated: Feb 7, 2026

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

1.2K
Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
06:40

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

4.4K
Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology
05:13

Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology

Published on: June 13, 2025

775

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Microbiology

Background:

  • Helicobacter pylori (H. pylori) infection is a primary cause of gastroduodenal ulcers and gastric cancer.
  • Evolving epidemiology, antibiotic resistance, and treatment indications necessitate reassessment of H. pylori management.
  • H. pylori is now recognized as an infection regardless of symptomatic presentation.

Purpose of the Study:

  • To review current, evidence-based medical management strategies for H. pylori infection.
  • To incorporate recent international consensus reports and national guidelines into clinical practice.
  • To provide updated recommendations for H. pylori eradication.

Main Methods:

  • Selective literature search of PubMed and Cochrane Database.
  • Inclusion of three international consensus reports.
  • Consideration of the updated German S2k guideline for H. pylori management.

Main Results:

  • H. pylori detection utilizes noninvasive (13C-urea breath test, stool antigen) and invasive (histology, culture, rapid urease test) methods.
  • High primary clarithromycin resistance (10.9% in Germany) impacts treatment choices.
  • Standard triple therapy or bismuth-containing quadruple therapy are primary options; 10-14 day courses improve eradication rates.
  • Gastritis risk stratification via endoscopic biopsy is recommended for H. pylori-positive patients over 50.

Conclusions:

  • Recent clinical developments facilitate evidence-based management of H. pylori infection.
  • Updated guidelines and consensus reports provide a framework for effective H. pylori eradication.
  • Tailored H. pylori treatment strategies are essential due to resistance patterns and patient factors.